Renasant Bio

Berkeley, CA · Founded 2022 · Privately Held (backing)

Operator of a biopharmaceutical research platform intended to develop oral small-molecule therapies for genetic kidney disorders. Renasant Bio is based in Berkeley, CA and was founded in 2022. It was valued at $78 million at its seed round in Jun 2025, the last priced event on record. It has raised $55.5 million across 2 recorded rounds; the latest was a $30 million early-stage round in Jun 2025.

PMV mark · valuation
$78.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$55.5M
Last round
Early Stage VC
Jun 2025

Who backs Renasant Bio?

5 investors
InvestorType
Qiming Venture Partners USAVenture capital
OrbiMedGrowth equity
Atlas VentureOther
5AM VenturesPE / buyout
Yale School of Medicine—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Renasant Bio investors

5 investors are on record for Renasant Bio, including Qiming Venture Partners USA, OrbiMed, Atlas Venture and 5AM Ventures. The early-stage round in Jun 2025 drew 4 investors.

Free account
More of Renasant Bio with a free account
  • ·Watch Renasant Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Renasant Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View